Co-culture with fibroblasts in stiff 3D scaffolds increases CD54 and CD140a expression on macrophages - Report - MDSpire

Co-culture with fibroblasts in stiff 3D scaffolds increases CD54 and CD140a expression on macrophages

  • By

  • Jennessa WX Ng

  • Santosh TRB Rao

  • Emily H. Field

  • Kaitlyn Ritchie

  • Mark D. Wright

  • Nicholas P. Reynolds

  • Sean W. Cutter

  • Katrina J. Binger

  • June 3, 2026

  • 0 min

Share

Clinical Report: Fibroblast Co-culture in Rigid 3D Scaffolds Enhances CD54 and CD140a Levels in Macrophages

Overview

This study demonstrates that co-culturing bone-marrow derived macrophages and mouse embryonic fibroblasts in three-dimensional scaffolds significantly enhances the expression of CD54 and CD140a in macrophages, dependent on the stiffness of the scaffold. These findings underscore the importance of mechanical cues in macrophage-fibroblast interactions within fibrotic microenvironments.

Background

Vascular fibrosis is a critical factor in the development of hypertension and cardiovascular diseases, driven by excessive extracellular matrix deposition and tissue stiffening. Understanding the interactions between macrophages and fibroblasts in this context is essential for developing targeted therapies. Traditional two-dimensional culture systems do not accurately reflect the physiological conditions of human tissues, necessitating the use of three-dimensional models to study these interactions.

Data Highlights

ConditionCD54 ExpressionCD140a Expression
200 Pa ScaffoldBaselineBaseline
2000 Pa ScaffoldIncreasedIncreased

Key Findings

  • Macrophages co-cultured with fibroblasts in 3D scaffolds showed increased viability across different stiffness levels.
  • CD54 and CD140a levels in macrophages were significantly upregulated in stiffer scaffolds.
  • Direct cell-cell interactions between macrophages and fibroblasts were infrequent, indicating that soluble factors and mechanical cues drive macrophage phenotype changes.
  • The study provides a novel platform for investigating the mechanisms of vascular fibrosis.
  • Understanding these interactions may inform therapeutic strategies for hypertension and cardiovascular disease.

Clinical Implications

The findings suggest that targeting mechanical properties of the extracellular matrix could influence macrophage behavior and potentially mitigate vascular fibrosis. Clinicians should consider the role of mechanical cues in the pathophysiology of hypertension and cardiovascular diseases when developing treatment strategies.

Conclusion

This research highlights the critical role of three-dimensional culture systems in studying macrophage-fibroblast interactions and their implications for vascular fibrosis. Further exploration of these mechanisms may lead to innovative therapeutic approaches for managing cardiovascular diseases.

Related Resources & Content

  1. Journal of Crohn's and Colitis, 2023 -- Eicosatetraynoic Acid Modulates Profibrotic Pathways in a Human Intestinal Organoid Model with Macrophages Derived from Induced Pluripotent Stem Cells in Crohn's Disease
  2. Frontiers in Immunology, 2026 -- Targeting macrophages in liver fibrosis
  3. Gastric Cancer, 2014 -- Bone Marrow-Derived Fibrocytes Play a Role in Tumor Growth and Fibrosis in Gastric Cancer
  4. Basic Research in Cardiology, 2022 -- Activation of Resident Cardiac Macrophages through Chemical and Mechanical Stimuli in an Ex Vivo Myocardial Slice Model
  5. JACC, 2025 -- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
  6. American College of Cardiology, 2025 -- Colchicine vs. Placebo Reduces MACE in Patients With Vascular Disease
  7. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC
  8. Colchicine vs. Placebo Reduces MACE in Patients With Vascular Disease - American College of Cardiology
  9. Frontiers | Evolving role of myocardial fibrosis in heart failure with preserved ejection fraction

Original Source(s)

Related Content